CS27892A3 - Benzyloxyphenyl derivatives, process of their preparation andpharmaceutical compositions comprising thereof - Google Patents

Benzyloxyphenyl derivatives, process of their preparation andpharmaceutical compositions comprising thereof Download PDF

Info

Publication number
CS27892A3
CS27892A3 CS92278A CS27892A CS27892A3 CS 27892 A3 CS27892 A3 CS 27892A3 CS 92278 A CS92278 A CS 92278A CS 27892 A CS27892 A CS 27892A CS 27892 A3 CS27892 A3 CS 27892A3
Authority
CS
Czechoslovakia
Prior art keywords
group
och
formula
compound
hydrogen
Prior art date
Application number
CS92278A
Other languages
Czech (cs)
English (en)
Inventor
Peter Dr Nussbaumer
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of CS27892A3 publication Critical patent/CS27892A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/53—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/54—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/60—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/84—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
    • C07C69/92—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with etherified hydroxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
CS92278A 1991-02-01 1992-01-30 Benzyloxyphenyl derivatives, process of their preparation andpharmaceutical compositions comprising thereof CS27892A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4103003 1991-02-01
DE4110478 1991-03-30

Publications (1)

Publication Number Publication Date
CS27892A3 true CS27892A3 (en) 1992-12-16

Family

ID=25900677

Family Applications (1)

Application Number Title Priority Date Filing Date
CS92278A CS27892A3 (en) 1991-02-01 1992-01-30 Benzyloxyphenyl derivatives, process of their preparation andpharmaceutical compositions comprising thereof

Country Status (15)

Country Link
EP (1) EP0497740B1 (no)
JP (1) JPH0570400A (no)
AT (1) ATE115541T1 (no)
AU (1) AU1058492A (no)
CA (1) CA2060352A1 (no)
CS (1) CS27892A3 (no)
DE (1) DE69200863D1 (no)
FI (1) FI920430A (no)
HU (1) HUT60458A (no)
IE (1) IE920335A1 (no)
IL (1) IL100805A0 (no)
MX (1) MX9200396A (no)
NO (1) NO920395L (no)
NZ (1) NZ241467A (no)
RO (1) RO107405B1 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6124343A (en) * 1919-01-27 2000-09-26 Rhone-Poulenc Rorer Limited Substituted phenyl compounds with a substituent having a thienyl ring
GB9121943D0 (en) * 1991-10-16 1991-11-27 Sandoz Ltd Organic compounds,processes for their production and their use
CN1056599C (zh) * 1993-01-01 2000-09-20 诺瓦蒂斯有限公司 双(苯基)乙烷衍生物
CN1101386C (zh) * 1995-03-14 2003-02-12 诺瓦蒂斯有限公司 三取代的苯基衍生物
JP3081773B2 (ja) * 1995-03-31 2000-08-28 株式会社資生堂 Ｎ−アシルピペラジン誘導体及び抗菌剤、抗潰瘍剤
JP4189043B2 (ja) * 1996-09-30 2008-12-03 株式会社資生堂 Ｎ−アシルピペラジン誘導体及び抗菌剤、抗潰瘍剤
CA2513092C (en) 2003-02-13 2011-11-01 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
JP2006523196A (ja) * 2003-03-11 2006-10-12 ニューロサーチ、アクティーゼルスカブ 新規ｋｃｎｑチャネルを調節する化合物及びその医薬用途
SE0400234D0 (sv) * 2004-02-06 2004-02-06 Active Biotech Ab New compounds, methods for their preparation and use thereof
SE0400235D0 (sv) 2004-02-06 2004-02-06 Active Biotech Ab New composition containing quinoline compounds
US8314124B2 (en) 2004-02-06 2012-11-20 Active Biotech Ab Crystalline salts of quinoline compounds and methods for preparing them
US7884208B2 (en) 2005-10-19 2011-02-08 Teva Pharmaceutical Industries, Ltd. Crystals of laquinimod sodium, and process for the manufacture thereof
AR061348A1 (es) 2006-06-12 2008-08-20 Teva Pharma Preparados estables de laquinimod
ATE508108T1 (de) * 2007-02-06 2011-05-15 Chelsea Therapeutics Inc Neue verbindungen, verfahren zu deren herstellung und deren verwendung
DK2234485T3 (da) 2007-12-20 2014-02-10 Teva Pharma Stabile laquinimod-præparater
AU2009288108B2 (en) 2008-09-03 2013-10-17 Teva Pharmaceutical Industries, Ltd. 2-oxo-1,2-dihydro-quinoline modulators of immune function
CN102603544A (zh) * 2012-04-06 2012-07-25 南京大学 一种抗炎化合物、其制备及其用途
WO2014074381A1 (en) 2012-11-07 2014-05-15 Teva Pharmaceutical Industries Ltd. Amine salts of laquinimod
US9233927B2 (en) 2013-03-14 2016-01-12 Teva Pharmaceutical Industries, Ltd. Crystals of laquinimod sodium and improved process for the manufacture thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5643717U (no) * 1979-09-13 1981-04-21
JPS5713418U (no) * 1980-06-30 1982-01-23
JPS5758013U (no) * 1980-09-24 1982-04-06
JPS6231017U (no) * 1985-08-08 1987-02-24
JPS6394112U (no) * 1986-12-10 1988-06-17
JPH0356519U (no) * 1989-10-09 1991-05-30

Also Published As

Publication number Publication date
NO920395D0 (no) 1992-01-30
AU1058492A (en) 1992-08-06
IL100805A0 (en) 1992-09-06
NZ241467A (en) 1994-02-25
EP0497740B1 (en) 1994-12-14
FI920430A (fi) 1992-08-02
HU9200204D0 (en) 1992-04-28
DE69200863D1 (de) 1995-01-26
FI920430A0 (fi) 1992-01-30
CA2060352A1 (en) 1992-08-02
ATE115541T1 (de) 1994-12-15
MX9200396A (es) 1992-08-01
HUT60458A (en) 1992-09-28
NO920395L (no) 1992-08-03
IE920335A1 (en) 1992-08-12
EP0497740A1 (en) 1992-08-05
JPH0570400A (ja) 1993-03-23
RO107405B1 (ro) 1993-11-30

Similar Documents

Publication Publication Date Title
CS27892A3 (en) Benzyloxyphenyl derivatives, process of their preparation andpharmaceutical compositions comprising thereof
EP1773757B1 (en) Trpv1 agonists, formulations containing them and uses thereof
US20170202795A1 (en) Small molecule inhibitors of stat3 with anti-tumor activity
WO1999065449A2 (en) INHIBITORS OF TRANSCRIPTION FACTOR NF-λB
TW200901961A (en) Substituted fused-ring compounds for inflammation and immune-related uses
KR102430906B1 (ko) Ppar 효능제, 화합물, 제약 조성물, 및 그의 사용 방법
ZA200206072B (en) Aniline-derived ligands for the thyroid receptor.
US10772876B2 (en) Enhancers of Notch signaling and the use thereof in the treatment of cancers and malignancies medicable by upregulation of Notch
TW201443001A (zh) 雙環止痛化合物
EP2765128A1 (en) Substituted benzamides with activity towards EP4 receptors
US20180237399A1 (en) Compounds having agonistic effect against gpr84, preparation method for compounds and use of compounds
JP2008530073A (ja) Ｈｍ７４ａ受容体で活性なアントラニル酸誘導体
NZ240403A (en) N-aryl-3-cycloalkyl propanamide nitrile derivatives and pharmaceutical compositions
EP1891026B1 (en) Cycloalkylidene compounds as selective estrogen receptor modulators
Zheng et al. Design and synthesis optimization of novel diimide indoles derivatives for ameliorating acute lung injury through modulation of NF-κB signaling pathway
JP5284964B2 (ja) ５員複素環化合物
JP5399248B2 (ja) ３環系アミド化合物
CZ282473B6 (cs) Bis(fenyl)ethanové deriváty, způsob jejich přípravy a farmaceutická kompozice tyto deriváty obsahující
JP2020511427A (ja) 新規の芳香族化合物
US20090270470A1 (en) Compounds I
JP2003055209A (ja) フェニルナフチル尿素誘導体
WO2008052288A1 (en) Dithiole compounds as cox inhibitors
KR890000798B1 (ko) N-나프토일글리신 유도체의 제조방법
JPH07258168A (ja) １３−オキシインゲノール誘導体